← All companiesVViridian Therapeutics, Inc.DE
VRDN - CIK 0001590750
Viridian Therapeutics, Inc.DE revenue by year
Viridian Therapeutics, Inc.DE (VRDN) reported revenue of $70.85M for fiscal year 2025, as filed in its audited annual report with the SEC.
VRDN annual revenue
VRDN revenue 2013-2025
| Fiscal year | Revenue | Change |
|---|
| FY 2025 | $70.85M | +23359.9% |
| FY 2024 | $302.00K | -3.8% |
| FY 2023 | $314.00K | -82.3% |
| FY 2022 | $1.77M | -40.2% |
| FY 2021 | $2.96M | +182.2% |
| FY 2020 | $1.05M | -76.5% |
| FY 2019 | $4.46M | -46.8% |
| FY 2018 | $8.39M | +109.5% |
| FY 2017 |
Revenue of similar companies
Frequently asked questions
How much revenue does Viridian Therapeutics, Inc.DE make?
Viridian Therapeutics, Inc.DE (VRDN) reported revenue of $70.85M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Viridian Therapeutics, Inc.DE's revenue changed over time?
Between fiscal 2013 and fiscal 2025, Viridian Therapeutics, Inc.DE's revenue grew from $5.49M to $70.85M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.